Checklists implementation in radiotherapy: Is it useful?  by Prieto, I. et al.
reports of practical oncology and radiotherapy 1 8 ( 2 0 1 3 ) S282–S288 S283
them due to clinical progression and 17 from other causes). Also, 9.9% (12/121) the reason was toxicity (7/12 rectal cancer with
concomitant chemotherapy, 5/12 with capecitabine).
Conclusions. The number of patients who did not begin or not end radiotherapy treatment is low, showing good judgment in
indications and patient selection. The most frequent reason was clinical progression. Rectal cancer treated with concomitant
chemotherapy was the most frequent reason of the interruption of radiotherapy for toxicity.
http://dx.doi.org/10.1016/j.rpor.2013.03.351
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Introduction. Radiotherapy is a very safe and effective treatment for cancer disease. However, errors and near-misses occur and
could impact safety and well-being of patients. Automated checklists have been applied successfully in other ﬁelds as a way of
systematically reducing risk.
Objectives. To analyze the experience regarding the implementation of checklists to help speciﬁc processes in radiation oncology,
to analyze its applicability, requirements and advantages, and to suggest a useful design of this kind of tool.
Methods and materials. We have reviewed international documents and published works with recommendations regarding safety
in radiation oncology. These recommendations have been written by worldwide authoritative organizations trying to make an
attempt to identify the measures that will make radiotherapy safer. Furthermore, we have extracted some basic points to select
the best format and the sequence of steps to develop and implement a useful automated checklist.
Results. Automated checklists have been implemented in some radiation oncology departments improving the safety in some
of their procedures. Checklists implementation has demonstrated to decrease errors and near-misses incidence and to reduce
the need for reworking of processes, especially those related to new and complex treatment techniques. All the above improves
global efﬁciency and quality. It should be noted, however, that a necessarily amount of time should be devoted previously for
implementing, designing and routine automated ﬁlling out. Before the design of these automated lists, a customized map of
risk of each department should be accomplished and the riskiest areas in the process of care for radiotherapy should be clearly
identiﬁed. Each team member must collaborate in the design, implementation and list ﬁll out to ensure the right execution,
create safer procedures and promote the safety culture. The standard format proposed worldwide for these automated checking
process is by means of close questions previously designed.
Conclusions. Creating an error-free environment is an essential part of any radiation oncology department. In this regard, checklist
implementation has demonstrated to be a useful tool that should be carefully designed after analyzing each radiation oncology
department globally and each procedure in detail, always keeping in mind staff and equipment features.
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Background. Lumpectomy followed by radiation therapy (RT) is a safe alternative to mastectomy in women with in situ or invasive
breast cancer who desire breast conservation.
Objective. We evaluated the direct cost associated to the different RT options.
Materials and methods. We performed a cost analysis among: (1) 3-dimensional conformal RT (3DCRT) using a conventional frac-
tionation (33 sessions [25 for the whole breast and 8 for the boost]); (2) hypofractionated 3DCRT (33 sessions [15 for the whole
breast and 8 for the boost]); (3) PBI delivered using: 3DCRT, high and low dose rate brachytherapy (HDR and LDR, respectively)
and intraoperative RT (IORT). Treatment costs included: number of fractions, hospitalization (i.e. LDR brachytherapy), consults
(initial consult and weekly visits during treatment; nurse consults; anesthesiologist if needed), radiological examinations (i.e.
portal veriﬁcation ﬁlms, planning computed tomography scans), blood tests, and dosimetry calculation. No costswere considered
for systemic treatments, post-RT follow-up, transportation, accommodation, or meals. Prices of treatment and patient support
were obtained from the last update of the authorized government agencies (Autonomous government of Andalusia; BOJA 210;
October 2005) at regular ofﬁcial prices. According the Spanish Association for Health Economy, the prices were updated until
2012, increasing the 3% per year to the total amount calculated.
